Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins Academic Article uri icon

Overview

MeSH Major

  • Genetic Therapy
  • Herpesvirus 4, Human
  • Immunotherapy, Adoptive
  • Lymphoma
  • T-Lymphocytes, Cytotoxic
  • Viral Matrix Proteins

abstract

  • Autologous T cells directed to the LMP2 or LMP1 and LMP2 antigens can induce durable complete responses without significant toxicity. Their earlier use in the disease course may reduce delayed treatment-related mortality.

publication date

  • March 10, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3940538

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.51.5304

PubMed ID

  • 24344220

Additional Document Info

start page

  • 798

end page

  • 808

volume

  • 32

number

  • 8